786,690 promoter warrants converted into equity shares
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board approved converting 786,690 warrants into fully paid equity shares for promoters at Rs 89 per share, including a Rs 79 premium. The company received Rs 5,25,11,557.50, equal to 75% of the issue price. Paid-up capital rose from Rs 10,91,41,250 to Rs 11,70,08,150, while total shares rose from 1,09,14,125 to 1,17,00,815.
Promoters receive 786,690 shares; the company gets Rs 5.25 crore in cash. These shares equal 6.7% of the enlarged count, diluting existing holders.